196 related articles for article (PubMed ID: 36652189)
21. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.
Li J; Hall IJ; Zhao G
Cancer Causes Control; 2017 Mar; 28(3):235-240. PubMed ID: 28210882
[TBL] [Abstract][Full Text] [Related]
23. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
[TBL] [Abstract][Full Text] [Related]
24. Prostate Cancer Screening and Young Black Men: Can Early Communication Avoid Later Health Disparities?
Miller DB; Markt SC; Nguyen CT; Coleman OC
J Cancer Educ; 2022 Oct; 37(5):1460-1465. PubMed ID: 33689157
[TBL] [Abstract][Full Text] [Related]
25. "Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?
Golijanin B; Bhatt V; Homer A; Malshy K; Ochsner A; Wales R; Khaleel S; Mega A; Pareek G; Hyams E
Cancer Epidemiol; 2024 Feb; 88():102492. PubMed ID: 38056246
[TBL] [Abstract][Full Text] [Related]
26. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.
Han PK; Coates RJ; Uhler RJ; Breen N
Am J Prev Med; 2006 May; 30(5):394-404. PubMed ID: 16627127
[TBL] [Abstract][Full Text] [Related]
27. Decision fatigue in low-value prostate cancer screening.
Hunt TC; Ambrose JP; Haaland B; Kawamoto K; Dechet CB; Lowrance WT; Hanson HA; O'Neil BB
Cancer; 2021 Sep; 127(18):3343-3353. PubMed ID: 34043813
[TBL] [Abstract][Full Text] [Related]
28. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
Hayat Roshanai A; Nordin K; Berglund G
Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
[TBL] [Abstract][Full Text] [Related]
29. Physician-patient discussions with african american men about prostate cancer screening.
Ross LE; Powe BD; Taylor YJ; Howard DL
Am J Mens Health; 2008 Jun; 2(2):156-64. PubMed ID: 19477779
[TBL] [Abstract][Full Text] [Related]
30. Examination of prostate-specific antigen (PSA) screening in military and civilian men: analysis of the 2018 behavioral risk factor surveillance system.
Hoffman SS; Smith AW; Kent EE; Doria-Rose VP; Kobrin SC; Mollica MA
Cancer Causes Control; 2022 Mar; 33(3):393-402. PubMed ID: 35034262
[TBL] [Abstract][Full Text] [Related]
31. Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020.
Pirsl F; Keruly JC; Moore RD; Lau B; Joshu CE
Prev Med; 2024 Jul; 184():108000. PubMed ID: 38735585
[TBL] [Abstract][Full Text] [Related]
32. Are Men Making Informed Decisions According to the Prostate-Specific Antigen Test Guidelines? Analysis of the 2015 Behavioral Risk Factor Surveillance System.
Cooper DL; Rollins L; Slocumb T; Rivers BM
Am J Mens Health; 2019; 13(2):1557988319834843. PubMed ID: 30836815
[TBL] [Abstract][Full Text] [Related]
33. Five-year downstream outcomes following prostate-specific antigen screening in older men.
Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
[TBL] [Abstract][Full Text] [Related]
34. Correlates of prostate-specific antigen testing in a large multiethnic cohort.
Haque R; Van Den Eeden SK; Jacobsen SJ; Caan B; Avila CC; Slezak J; Sternfeld B; Loo RK; Quinn VP
Am J Manag Care; 2009 Nov; 15(11):793-9. PubMed ID: 19895183
[TBL] [Abstract][Full Text] [Related]
35. Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.
Kushalnagar P; Hill C; Carrizales S; Sadler GR
J Cancer Educ; 2020 Feb; 35(1):28-35. PubMed ID: 30353474
[TBL] [Abstract][Full Text] [Related]
36. The effect of physician-patient discussions on the likelihood of prostate-specific antigen testing.
Ross LE; Richardson LC; Berkowitz Z
J Natl Med Assoc; 2006 Nov; 98(11):1823-9. PubMed ID: 17128693
[TBL] [Abstract][Full Text] [Related]
37. Does a prior cancer diagnosis impact PSA testing? Results from the National Health Interview Survey.
Lazarovich A; Chandrasekar T; Basnet A; Bratslavsky G; Goldberg H
Can J Urol; 2023 Jun; 30(3):11551-11557. PubMed ID: 37344467
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
39. Fostering shared decision-making about prostate cancer screening among African American men patients and their primary care providers: a randomized behavioral clinical trial.
Echeverri M; Felder K; Anderson D; Apantaku E; Leung P; Hoff C; Dennar P
Trials; 2022 Aug; 23(1):653. PubMed ID: 35964061
[TBL] [Abstract][Full Text] [Related]
40. Low-Value Prostate-Specific Antigen Screening in Older Males.
Kalavacherla S; Riviere P; Javier-DesLoges J; Banegas MP; McKay RR; Murphy JD; Rose BS
JAMA Netw Open; 2023 Apr; 6(4):e237504. PubMed ID: 37040113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
